Cargando…
Pharmacodynamic evaluation of suppression of in vitro resistance in Acinetobacter baumannii strains using polymyxin B-based combination therapy
The emergence of polymyxin resistance in Gram-negative bacteria infections has motivated the use of combination therapy. This study determined the mutant selection window (MSW) of polymyxin B alone and in combination with meropenem and fosfomycin against A. baumannii strains belonging to clonal line...
Autores principales: | Fedrigo, Nayara Helisandra, Shinohara, Danielle Rosani, Mazucheli, Josmar, Nishiyama, Sheila Alexandra Belini, Carrara-Marroni, Floristher Elaine, Martins, Frederico Severino, Zhu, Peijuan, Yu, Mingming, Sy, Sherwin Kenneth B., Tognim, Maria Cristina Bronharo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8167102/ https://www.ncbi.nlm.nih.gov/pubmed/34059725 http://dx.doi.org/10.1038/s41598-021-90709-2 |
Ejemplares similares
-
The combination effect of meropenem/sulbactam/polymyxin-B on the pharmacodynamic parameters for mutant selection windows against carbapenem-resistant Acinetobacter baumannii
por: Zhang, Jiayuan, et al.
Publicado: (2022) -
Effects of amikacin, polymyxin-B, and sulbactam combination on the pharmacodynamic indices of mutant selection against multi-drug resistant Acinetobacter baumannii
por: Zhu, Shixing, et al.
Publicado: (2022) -
Routine laboratory biomarkers used to predict Gram-positive or Gram-negative bacteria involved in bloodstream infections
por: Dambroso-Altafini, Daniela, et al.
Publicado: (2022) -
Metabolomics revealed mechanism for the synergistic effect of sulbactam, polymyxin-B and amikacin combination against Acinetobacter baumannii
por: Zhu, Shixing, et al.
Publicado: (2023) -
Metabolomic profiling of polymyxin-B in combination with meropenem and sulbactam against multi-drug resistant Acinetobacter baumannii
por: Zhu, Shixing, et al.
Publicado: (2022)